Format

Send to

Choose Destination
See comment in PubMed Commons below
Clin Transl Oncol. 2012 Dec;14(12):891-5. doi: 10.1007/s12094-012-0935-7. Epub 2012 Oct 2.

Role of gamma-delta T-cells in cancer: another opening door to immunotherapy.

Author information

1
Medical Oncology Department, University Hospital Arnau de Vilanova, Lleida, Spain. dmarmed@hotmail.com

Abstract

The gamma-delta (γδ) T-cells are a subset of T-lymphocytes characterized by the presence of a surface antigen recognition complex type 2. Those γδ T-cells represent 2-5 % of peripheral T-cells only, but they are common in organs and mucosae, acting as a first defense system in the entries to the organism. The γδ T-cells take part on immune response by direct cytolysis, development of memory phenotypes, and modulation of immune cells, and they have been implied in autoimmune disorders, immune deficiencies, infections, and tumor diseases. We reported the role of γδ T-cells in oncology, focusing in their potential applications for cancer treatment. Experimental designs and clinical trials in the treatment of solid malignancies are extensively reviewed.

PMID:
23054752
DOI:
10.1007/s12094-012-0935-7
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Springer
    Loading ...
    Support Center